https://www.selleckchem.com/pr....oducts/Sunitinib-Mal
To facilitate evidence-based medicine (EBM) on an individual level, it may be important for clinical practice guidelines (CPGs) to incorporate the performance parameters of diagnostic studies and therapeutic interventions (such as likelihood ratio and absolute benefit or harm), and to incorporate relevant patient contexts that may influence decision-making. We sought to determine the extent to which heart failure CPGs currently incorporate this information. We reviewed the American College of Cardiology Foundation/Amer
Like
Comment
Share
